Latest News by Industry
![CASTLE BIOSCIENCES INC [CSTL] reports annual net loss of $57,466,000.0](/_next/image?url=https%3A%2F%2F10kinfo-appdata.s3.us-west-2.amazonaws.com%2Fedgar0105%2FCompanyLogos%2FUS%2FCSTL.png&w=1200&q=75)
CASTLE BIOSCIENCES INC [CSTL] has reported a net loss of $57,466,000.0 for year ended Dec 31, 2023.
The Company said in a filing before the Securities and Exchange Commission that its total revenue for the year was $219.8 million
Based in FRIENDSWOOD, Texas, CASTLE BIOSCIENCES INC operates in the SERVICES sector.
The consolidated income statement for the 12 months ended December 31, 2023, and December 31, 2022, shows a comparison in financial performance.
Net Revenues:
- In the current reporting period (2023), net revenues amounted to $219.788 million.
- Comparatively, in the previous period (2022), net revenues were $137.039 million.
Operating Expenses and Other Operating Income:
1. Cost of Sales (exclusive of amortization of acquired intangible assets):
- 2023: $44.982 million
- 2022: $32.009 million
2. Research and Development:
- 2023: $53.618 million
- 2022: $44.903 million
3. Selling, General and Administrative Expenses:
- 2023: $180.152 million
- 2022: $143.003 million
4. Amortization of Acquired Intangible Assets:
- 2023: $9.013 million
- 2022: $8.266 million
5. Change in Fair Value of Contingent Consideration:
- 2023: $0 million
- 2022: ($18.287) million
Total Operating Expenses, Net:
- 2023: $287.765 million
- 2022: $209.894 million
Operating Loss:
- 2023: $(67.977) million
- 2022: $(72.855) million
Interest and Other Non-Operating Income:
- 2023: $10.623 million
- 2022: $3.968 million
Interest Expense:
- 2023: $(11) thousand
- 2022: $(17) thousand
Loss Before Income Taxes:
- 2023: $(57.365) million
- 2022: $(68.904) million
Income Tax Expense (Benefit):
- 2023: $101 thousand
- 2022: $(1.766) million
Net Loss:
- 2023: $(57.466) million
- 2022: $(67.138) million
Loss Per Share:
- Basic:
- 2023: $(2.14)
- 2022: $(2.58)
- Diluted:
- 2023: $(2.14)
- 2022: $(2.58)
Weighted-Average Shares Outstanding:
- Basic:
- 2023: 26.802 million shares
- 2022: 26.054 million shares
- Diluted:
- 2023: 26.802 million shares
- 2022: 26.054 million shares
This comparison highlights an increase in net revenues and operating expenses in the current reporting period compared to the previous one, leading to a slightly lower net loss per share in 2023.
Also Read: